GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
ERβ activation was found to reduce the expression of GULP1 as a direct downstream target in bladder cancer cells, resulting in the induction of cisplatin resistance.
Authors
- Takuo Matsukawa (ORCID: https://orcid.org/0009-0009-4418-399X)
- Guiyu Jiang
- Mohammad Amin Elahi Najafi
- Yukiko Teramoto
- Tomoyuki Tatenuma (ORCID: https://orcid.org/0000-0002-1908-4975)
- Takuro Goto (ORCID: https://orcid.org/0000-0002-1794-5049)
- Hiroshi Miyamoto (ORCID: https://orcid.org/0000-0002-3715-8894)
- Arati Sharma (ORCID: https://orcid.org/0000-0001-7178-949X)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Rochester Medical Center (US)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2024-10-28
- DOI
- https://doi.org/10.21873/cgp.20472
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.29